0,893  0,003  Caspase 9 stimulant
0,878  0,003  Sensitization
0,877  0,003  Antiseptic
0,851  0,003  Antimutagenic
0,840  0,004  Skin irritative effect
0,839  0,005  Antihypercholesterolemic
0,820  0,007  TNF expression inhibitor
0,816  0,004  Lipoxygenase inhibitor
0,808  0,005  Radioprotector
0,801  0,004  CTGF expression inhibitor
0,796  0,005  GST A substrate
0,775  0,005  Cholesterol antagonist
0,766  0,003  Ulceration
0,756  0,003  Monophenol monooxygenase inhibitor
0,748  0,005  Vasodilator, peripheral
0,751  0,016  Transcription factor NF kappa B inhibitor
0,734  0,004  Superoxide dismutase inhibitor
0,713  0,009  Chemoprotective
0,708  0,006  Eye irritation, high
0,672  0,004  Antihypoxic
0,669  0,003  Melanin inhibitor
0,670  0,005  Antipruritic, allergic
0,663  0,005  Vasodilator, coronary
0,654  0,002  Vanilloid 1 agonist
0,652  0,002  Succinate dehydrogenase inhibitor
0,656  0,008  Cardiovascular analeptic
0,645  0,006  Amyloid beta aggregation inhibitor
0,655  0,020  Teratogen
0,642  0,006  Antipyretic
0,661  0,037  Apoptosis agonist
0,638  0,014  Respiratory analeptic
0,629  0,009  Antioxidant
0,629  0,012  Chemopreventive
0,621  0,007  Free radical scavenger
0,625  0,021  Embryotoxic
0,607  0,005  FMO1 substrate
0,605  0,003  VCAM1 expression inhibitor
0,598  0,003  GST P1-1 substrate
0,609  0,015  Antithrombotic
0,597  0,005  Sulfotransferase substrate
0,595  0,004  Phospholipase C inhibitor
0,602  0,012  UGT1A9 substrate
0,605  0,018  Aldehyde oxidase inhibitor
0,596  0,011  NOS2 expression inhibitor
0,588  0,003  Carbonic anhydrase VI inhibitor
0,592  0,009  UGT1A6 substrate
0,595  0,013  Spasmolytic
0,589  0,009  Antiamyloidogenic
0,589  0,011  Histamine release inhibitor
0,574  0,003  Carbonic anhydrase XIII inhibitor
0,583  0,015  Mutagenic
0,601  0,035  Antineoplastic (breast cancer)
0,583  0,018  Carcinogenic
0,573  0,014  Proliferative diseases treatment
0,560  0,004  Mediator release inhibitor
0,553  0,004  Acaricide
0,553  0,005  Anesthetic general
0,564  0,017  Analeptic
0,540  0,006  UGT2B4 substrate
0,534  0,005  Amylase inhibitor
0,558  0,031  15-Lipoxygenase inhibitor
0,530  0,004  Protein kinase stimulant
0,528  0,006  Muscle relaxant
0,579  0,059  Antiinflammatory
0,536  0,022  CYP2C19 substrate
0,518  0,005  Skeletal muscle relaxant
0,511  0,005  Antidote
0,512  0,010  Antihypertriglyceridemic
0,537  0,039  Antineoplastic (lung cancer)
0,487  0,008  Skin whitener
0,498  0,021  Apoptosis antagonist
0,491  0,015  DNA damaging
0,479  0,008  Anesthetic
0,468  0,004  Antipruritic, non-allergic
0,472  0,008  UGT1A3 substrate
0,473  0,017  Cardiodepressant
0,479  0,024  12-Lipoxygenase inhibitor
0,456  0,003  Toll-Like receptor 2 antagonist
0,451  0,004  Carbonic anhydrase III inhibitor
0,455  0,012  UGT1A1 substrate
0,460  0,022  Antiprotozoal (Leishmania)
0,474  0,041  CYP2C9 substrate
0,475  0,044  Antileukemic
0,458  0,028  Antineoplastic (cervical cancer)
0,455  0,028  AR expression inhibitor
0,426  0,005  Insulin sensitizer
0,425  0,005  Glutathione S-transferase substrate
0,422  0,004  Antihelmintic (Nematodes)
0,436  0,027  ICAM1 expression inhibitor
0,422  0,014  P-glycoprotein inhibitor
0,412  0,006  Anesthetic local
0,432  0,027  Antineoplastic (non-small cell lung cancer)
0,425  0,021  Radiosensitizer
0,413  0,012  Non-steroidal antiinflammatory agent
0,410  0,010  Platelet adhesion inhibitor
0,434  0,034  Caspase 3 stimulant
0,437  0,044  Prostate cancer treatment
0,395  0,004  Choleretic
0,409  0,018  Antiulcerative
0,411  0,021  Vasodilator
0,392  0,002  Ornithine decarboxylase inhibitor
0,429  0,042  Antiallergic
0,420  0,034  Cardioprotectant
0,390  0,005  Phospholipase A2 inhibitor
0,436  0,058  5 Hydroxytryptamine release inhibitor
0,380  0,005  Xanthine oxidase inhibitor
0,408  0,037  Lipoprotein disorders treatment
0,397  0,027  Antiglaucomic
0,399  0,031  CYP1A2 inhibitor
0,411  0,044  5 Hydroxytryptamine release stimulant
0,401  0,038  NOS3 expression inhibitor
0,387  0,030  Hypoglycemic
0,376  0,020  Abortion inducer
0,368  0,013  Hair growth stimulant
0,383  0,030  Tumour necrosis factor alpha release inhibitor
0,357  0,007  5-Lipoxygenase inhibitor
0,362  0,013  Genotoxic
0,360  0,014  Tyrosine 3 hydroxylase inhibitor
0,366  0,022  Cyclic AMP phosphodiesterase inhibitor
0,355  0,012  Lipid peroxidase inhibitor
0,382  0,044  Antineoplastic (melanoma)
0,400  0,063  Immunosuppressant
0,364  0,030  Nitric oxide antagonist
0,362  0,031  Antiparasitic
0,346  0,015  Pneumotoxic
0,433  0,102  Alpha-glucosidase inhibitor
0,361  0,029  Transcription factor STAT3 inhibitor
0,358  0,029  Antineoplastic (endocrine cancer)
0,335  0,008  Cholesterol synthesis inhibitor
0,327  0,004  Keratolytic
0,376  0,059  Antineoplastic (colorectal cancer)
0,336  0,021  Antihypotensive
0,367  0,052  Antineoplastic (ovarian cancer)
0,373  0,058  Immunostimulant
0,348  0,036  Hypolipemic
0,320  0,008  Antifungal enhancer
0,348  0,037  FMO3 substrate
0,353  0,043  Cytotoxic
0,329  0,021  UGT2B7 substrate
0,335  0,030  5 Hydroxytryptamine uptake stimulant
0,308  0,005  UGT2B10 substrate
0,339  0,036  Angiogenesis stimulant
0,377  0,075  CYP2C19 inhibitor
0,309  0,009  Cystathionine beta-synthase inhibitor
0,304  0,005  Calcium antagonist
0,357  0,059  Antineoplastic (colon cancer)
0,318  0,020  DNA methyltransferase I inhibitor
0,299  0,002  Endocannabinoid uptake inhibitor
0,314  0,018  Interferon gamma antagonist
0,346  0,052  Calcium channel activator
0,333  0,041  Antineoplastic (renal cancer)
0,295  0,004  Leukotriene antagonist
0,321  0,031  UDP-glucuronosyltransferase substrate
0,298  0,009  Expectorant
0,328  0,039  Vascular (periferal) disease treatment
0,349  0,061  Antifungal
0,329  0,042  Antidiabetic symptomatic
0,303  0,017  CYP2B6 inhibitor
0,328  0,044  Platelet antagonist
0,326  0,044  Insulysin inhibitor
0,310  0,029  Antihelmintic
0,300  0,021  Carcinogenic, group 3
0,370  0,091  Antibacterial
0,339  0,062  CYP2D6 substrate
0,321  0,043  Myocardial infarction treatment
0,280  0,005  HIV-1 integrase (3'-Processing) inhibitor
0,278  0,004  Carbonic anhydrase XIV inhibitor
0,333  0,059  Antineoplastic (brain cancer)
0,302  0,029  Hepatoprotectant
0,292  0,020  Tubulin antagonist
0,271  0,003  Leukotriene B4 antagonist
0,303  0,037  Peroxidase inhibitor
0,342  0,076  Thyroid hormone antagonist
0,319  0,054  Antineoplastic (multiple myeloma)
0,321  0,060  CYP1A2 substrate
0,265  0,005  Vanilloid agonist
0,267  0,009  Antieczematic
0,316  0,059  Antineoplastic (osteosarcoma)
0,265  0,010  Antibacterial (Helicobacter pylori)
0,321  0,066  Antiischemic
0,264  0,009  Alcohol dehydrogenase substrate
0,304  0,050  Antineoplastic (liver cancer)
0,289  0,039  Antiparkinsonian, rigidity relieving
0,298  0,049  Interleukin agonist
0,259  0,013  Toll-Like receptor antagonist
0,296  0,050  GST M1-1 substrate
0,302  0,057  Antineoplastic (glioma)
0,249  0,005  Macrophage migration inhibitory factor inhibitor
0,249  0,006  HIV-1 integrase (Strand Transfer) inhibitor
0,247  0,004  Glutathione S-transferase inhibitor
0,277  0,035  DNA methylase inhibitor
0,298  0,057  Transcription factor STAT inhibitor
0,369  0,129  DNA directed DNA polymerase inhibitor
0,313  0,075  Hepatic disorders treatment
0,317  0,080  Thyroid hormone beta antagonist
0,253  0,016  Chelator
0,278  0,041  Platelet aggregation inhibitor
0,243  0,007  Arachidonic acid antagonist
0,242  0,010  Cyclooxygenase 3 inhibitor
0,322  0,090  CYP3A4 substrate
0,313  0,081  Bone diseases treatment
0,260  0,028  Tumour necrosis factor antagonist
0,280  0,050  Antimitotic
0,256  0,026  Antiparkinsonian, tremor relieving
0,247  0,017  Uterine stimulant
0,234  0,008  Aldehyde dehydrogenase substrate
0,250  0,028  MAO inhibitor
0,275  0,054  Antineoplastic (lymphocytic leukemia)
0,225  0,004  Heat shock protein 70 antagonist
0,235  0,015  Neurotrophic factor
0,233  0,013  Antirickettsial
0,235  0,015  Interleukin 4 antagonist
0,244  0,024  LDLR expression enhancer
0,251  0,032  Amyloid beta precursor protein antagonist
0,223  0,005  Carbonic anhydrase V inhibitor
0,280  0,064  Flavin-containing monooxygenase substrate
0,223  0,007  TRPA1 agonist
0,235  0,020  Antihyperlipoproteinemic
0,296  0,083  Sodium/bile acid cotransporter inhibitor
0,233  0,020  DNA polymerase I inhibitor
0,231  0,018  Phobic disorders treatment
0,250  0,038  Neurotrophic factor enhancer
0,264  0,054  Psychostimulant
0,289  0,081  Antipsoriatic
0,238  0,030  UGT2B15 substrate
0,282  0,075  Antiosteoporotic
0,209  0,005  Carbonic anhydrase VB inhibitor
0,212  0,009  Adenylate cyclase stimulant
0,225  0,022  Aldehyde dehydrogenase inhibitor
0,236  0,035  Protein-tyrosine phosphatase inhibitor
0,314  0,114  Antiprotozoal
0,208  0,008  Sphingomyelinase inhibitor
0,212  0,013  Catalase inhibitor
0,233  0,034  Antineoplastic (squamous cell carcinoma)
0,232  0,033  Antiacne
0,213  0,016  SULT1A1 substrate
0,256  0,061  Antineoplastic (glioblastoma multiforme)
0,207  0,014  Coagulant
0,203  0,012  Photosensitizer
0,197  0,007  Toll-Like receptor 4 antagonist
0,195  0,005  Carbonic anhydrase VA inhibitor
0,221  0,033  NOS3 expression enhancer
0,210  0,023  MAO B inhibitor
0,199  0,012  Gastric antisecretory
0,191  0,004  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,189  0,005  Acetylcholine release stimulant
0,199  0,016  UGT2B1 substrate
0,215  0,032  UGT2B9 substrate
0,188  0,005  UGT2B11 substrate
0,191  0,010  Prolactin inhibitor
0,216  0,036  VEGF expression inhibitor
0,207  0,030  Interleukin 1 antagonist
0,181  0,007  Antiviral (Rhinovirus)
0,222  0,049  UGT1A4 substrate
0,259  0,088  Antineoplastic (pancreatic cancer)
0,230  0,059  Septic shock treatment
0,193  0,022  Microtubule formation inhibitor
0,242  0,071  Cytostatic
0,182  0,012  NAD(P)H dehydrogenase (quinone) inhibitor
0,203  0,033  M18 aspartyl aminopeptidase inhibitor
0,183  0,014  Antiviral (Influenza B)
0,205  0,036  Corneal wound healing stimulator
0,204  0,036  Antineoplastic (bone cancer)
0,196  0,030  Protein-tyrosine phosphatase 1B inhibitor
0,175  0,011  Thioredoxin inhibitor
0,236  0,072  Antineoplastic (lymphoma)
0,200  0,037  ATPase inhibitor
0,246  0,085  Antiprotozoal (Trypanosoma)
0,177  0,017  Dementia treatment
0,193  0,033  SULT1A3 substrate
0,169  0,010  Antifungal (Pneumocystis)
0,236  0,077  DNA synthesis inhibitor
0,193  0,035  Acetylcholinesterase inhibitor
0,177  0,019  Gastritis treatment
0,176  0,020  Mucolytic
0,172  0,017  Vascular dementia treatment
0,168  0,015  Ca2+-transporting ATPase inhibitor
0,195  0,042  CNS active muscle relaxant
0,176  0,026  Interleukin 1b antagonist
0,179  0,030  Farnesoid X receptor antagonist
0,165  0,016  Actinic keratosis treatment
0,190  0,041  Neurotensin receptor agonist
0,180  0,033  Alkylator
0,213  0,066  Antiviral (Influenza)
0,161  0,015  Electron transport complex I inhibitor
0,171  0,025  Bronchodilator
0,150  0,004  Antiviral (Parainfluenza)
0,174  0,029  Carcinogenic, group 2B
0,216  0,073  Antineoplastic enhancer
0,270  0,128  Stroke treatment
0,202  0,061  Myocardial ischemia treatment
0,217  0,076  Interleukin antagonist
0,166  0,025  Carbonic anhydrase XV inhibitor
0,147  0,006  Peroxisome proliferator-activated receptor alpha agonist
0,182  0,042  Cyclooxygenase 1 inhibitor
0,243  0,107  Hypoxia-inducible factor 1 alpha inhibitor
0,257  0,123  Prostaglandin dehydrogenase inhibitor
0,187  0,053  Restenosis treatment
0,161  0,028  Sphingosine 1-phosphate receptor 2 antagonist
0,155  0,022  Breast cancer-resistant protein inhibitor
0,215  0,082  Peptidyltransferase inhibitor
0,196  0,063  Dual specificity phosphatase 3 inhibitor
0,167  0,035  Antihemorrhagic
0,153  0,022  Estrogen antagonist
0,138  0,007  Anticholelithogenic
0,166  0,035  Antihelmintic (Trematoda)
0,153  0,023  Beta glucuronidase inhibitor
0,201  0,072  Sedative
0,140  0,011  Prostaglandin EP2 antagonist
0,166  0,037  Cell adhesion inhibitor
0,186  0,059  Thrombolytic
0,246  0,124  Antihypertensive
0,153  0,031  Sphingosine 1-phosphate receptor 4 antagonist
0,132  0,012  HIV-1 integrase inhibitor
0,195  0,077  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,157  0,039  MAO A inhibitor
0,184  0,067  Lipocortins synthesis antagonist
0,243  0,127  Interleukin 2 agonist
0,125  0,010  Xanthine dehydrogenase inhibitor
0,172  0,058  Antiviral (Influenza A)
0,155  0,042  Adenylate cyclase inhibitor
0,183  0,071  Antianginal
0,128  0,016  Beta tubulin antagonist
0,216  0,104  Antineoplastic (sarcoma)
0,134  0,022  Paget's disease treatment
0,178  0,068  Dual specificity phosphatase inhibitor
0,114  0,005  Glucose-6-phosphate translocase inhibitor
0,162  0,054  Cytokine production inhibitor
0,167  0,059  Antineoplastic (carcinoma)
0,144  0,036  Butyrylcholinesterase inhibitor
0,222  0,116  Gastrin inhibitor
0,202  0,097  RNA-directed DNA polymerase inhibitor
0,120  0,016  Granulocyte macrophage colony stimulating factor agonist
0,155  0,054  Sphingosine 1-phosphate receptor 5 antagonist
0,245  0,144  Antiprotozoal (Plasmodium)
0,159  0,058  Antiprotozoal (Coccidial)
0,117  0,018  Thioredoxin reductase inhibitor
0,111  0,012  Beta adrenoreceptor antagonist
0,161  0,062  Cyclooxygenase inhibitor
0,102  0,004  Lysophosphatidic acid 2 receptor antagonist
0,153  0,056  Bone formation stimulant
0,117  0,020  CDC25A inhibitor
0,115  0,019  Leukotriene synthesis inhibitor
0,111  0,015  Estrogen-related receptor beta agonist
0,117  0,021  Peroxisome proliferator-activated receptor gamma agonist
0,103  0,007  Nitric oxide donor
0,100  0,005  Squalene epoxidase inhibitor
0,161  0,066  Carcinogenic, group 1
0,109  0,014  Antidote, heavy metal
0,131  0,037  Multidrug resistance-associated protein 1 inhibitor
0,163  0,069  Antiviral (Herpes)
0,133  0,039  AMP-activated protein kinase stimulant
0,106  0,013  GABA B receptor agonist
0,272  0,180  DNA polymerase beta inhibitor
0,101  0,009  Carbonic anhydrase VII inhibitor
0,134  0,042  Caspase 3 inhibitor
0,112  0,021  Estrogen receptor alpha antagonist
0,110  0,018  SULT1A2 substrate
0,105  0,014  CDC25B inhibitor
0,104  0,014  Alpha tubulin antagonist
0,114  0,024  ATPase (Vacuolar H+) inhibitor
0,104  0,015  Maillard reaction inhibitor
0,203  0,114  Neuropeptide Y2 antagonist
0,242  0,154  Antineoplastic (small cell lung cancer)
0,115  0,027  Histidine decarboxylase inhibitor
0,181  0,093  Pyruvate kinase inhibitor
0,140  0,052  Proteasome inhibitor
0,093  0,006  Lysophosphatidic acid 3 receptor antagonist
0,092  0,005  Prostaglandin agonist
0,115  0,028  Interleukin 5 antagonist
0,091  0,005  Leukotriene C antagonist
0,098  0,013  Antimycoplasmal
0,171  0,087  Wound healing agent
0,114  0,031  Phosphodiesterase 6D inhibitor
0,106  0,024  Lipase inhibitor
0,126  0,046  HDL-cholesterol increasing
0,120  0,040  Anabolic
0,089  0,010  Potassium channel Kv1.3 blocker
0,272  0,194  Alzheimer's disease treatment
0,086  0,008  Vanilloid 2 antagonist
0,090  0,013  Beta 1 adrenoreceptor antagonist
0,255  0,179  Antiparkinsonian
0,111  0,036  Antispirochetal
0,131  0,057  Antiviral (Papilloma)
0,146  0,073  Thiol protease inhibitor
0,197  0,123  Antiviral (West Nile virus)
0,103  0,030  Antiviral (Hepatitis A)
0,155  0,082  Sigma receptor agonist
0,089  0,016  Exportin-1 inhibitor
0,122  0,051  Gout treatment
0,081  0,011  Thromboxane synthase inhibitor
0,090  0,020  Protease 3C (Human rhinovirus) inhibitor
0,089  0,020  Neuraminidase inhibitor
0,102  0,033  Cell adhesion molecule inhibitor
0,097  0,030  Antiviral (Dengue virus)
0,099  0,033  Na+ K+ transporting ATPase inhibitor
0,146  0,080  Cholinergic
0,208  0,143  Antimycobacterial
0,110  0,046  Estrogen receptor beta antagonist
0,263  0,198  Antidiabetic
0,263  0,198  Cyclophilin D inhibitor
0,102  0,038  Topoisomerase II alpha inhibitor
0,128  0,065  Antineoplastic (uterine cancer)
0,084  0,022  Aldose reductase inhibitor
0,106  0,044  ABCA1 expression enhancer
0,125  0,063  Growth stimulant
0,112  0,051  Adenylate kinase inhibitor
0,125  0,063  Antiprotozoal (Amoeba)
0,194  0,133  Antituberculosic
0,103  0,043  Bile acid receptor antagonist
0,089  0,029  Glycine receptor agonist
0,156  0,096  Antineoplastic (gastric cancer)
0,174  0,115  Antiviral (Ebola)
0,082  0,024  Neuraminidase (influenza) inhibitor
0,143  0,084  Raynaud's phenomenon treatment
0,062  0,005  Leukotriene C4 antagonist
0,105  0,049  Uric acid excretion stimulant
0,149  0,094  Liver fibrosis treatment
0,071  0,016  Beta 2 adrenoreceptor antagonist
0,090  0,036  Glutamate decarboxylase inhibitor
0,120  0,067  Antineoplastic antimetabolite
0,057  0,005  Leukotriene B4 receptor 1 antagonist
0,086  0,034  Calcium channel L-type blocker
0,085  0,033  Sphingosine 1-phosphate receptor 4 agonist
0,070  0,019  Plasminogen activator inhibitor antagonist
0,083  0,033  Elastase 1 inhibitor
0,084  0,034  Antitreponemal
0,075  0,025  Transcription factor AP-1 inhibitor
0,056  0,007  Catechol O-methyltransferase inhibitor
0,268  0,219  Antineoplastic (solid tumors)
0,063  0,015  Factor III inhibitor
0,061  0,013  Retinoid X receptor agonist
0,093  0,046  Transcription factor NF kappa B stimulant
0,119  0,072  Contraceptive female
0,055  0,009  Retinoid X receptor antagonist
0,125  0,079  Cocaine dependence treatment
0,080  0,034  Peroxisome proliferator-activated receptor gamma antagonist
0,070  0,025  Sphingosine kinase inhibitor
0,122  0,077  Papain-like protease (SARS coronavirus) inhibitor
0,122  0,078  Cyclooxygenase 2 inhibitor
0,134  0,093  Antidiarrheal
0,072  0,031  Beta 3 adrenoreceptor antagonist
0,168  0,128  Antiviral (HIV)
0,063  0,023  Glycine transporter 2 inhibitor
0,097  0,058  Interleukin 12 antagonist
0,044  0,005  Prostaglandin F2 alpha agonist
0,044  0,006  Calcium-independent phospholipase A2 inhibitor
0,047  0,009  GABA transporter 3 inhibitor
0,060  0,023  Heparanase inhibitor
0,065  0,029  Thromboxane antagonist
0,063  0,026  Thromboxane A2 antagonist
0,050  0,014  Kainate receptor agonist
0,043  0,008  Prostaglandin EP2 agonist
0,111  0,076  Shock treatment
0,062  0,027  Pregnane X receptor antagonist
0,063  0,029  Postcoital contraceptive
0,080  0,046  GABA aminotransferase inhibitor
0,110  0,077  Beta amyloid protein antagonist
0,044  0,011  Retinoid X alpha receptor antagonist
0,092  0,061  Alcohol dehydrogenase inhibitor
0,116  0,085  Retinoprotector
0,062  0,032  Lipocortins synthesis agonist
0,061  0,030  Sphingosine kinase 2 inhibitor
0,119  0,089  Antiprotozoal (Trichomonas)
0,071  0,042  Selectin antagonist
0,216  0,188  GABA C receptor rho-3 antagonist
0,062  0,033  Human rhinovirus A protease inhibitor
0,064  0,036  Heme oxygenase stimulant
0,122  0,095  Pancreatic disorders treatment
0,075  0,048  Metalloproteinase-9 inhibitor
0,043  0,016  Peroxisome proliferator-activated receptor delta agonist
0,090  0,063  Falcipain inhibitor
0,112  0,086  Cathepsin H inhibitor
0,035  0,009  Prostaglandin E2 agonist
0,173  0,146  Nitric-oxide synthase stimulant
0,067  0,041  Hyperparathyroidism treatment
0,090  0,064  SULT1E1 substrate
0,087  0,062  Falcipain 2 inhibitor
0,033  0,009  Lysophosphatidic acid receptor 1 agonist
0,029  0,006  Isoleucine-tRNA ligase inhibitor
0,065  0,041  Transcription factor RelA inhibitor
0,221  0,198  CYP2C9 inhibitor
0,057  0,034  Adenine nucleotide translocase inhibitor
0,146  0,123  Toxic, respiratory center
0,099  0,077  DOPA decarboxylase inhibitor
0,031  0,008  Leukotriene B4 receptor 2 antagonist
0,093  0,072  Antifungal (Candida)
0,031  0,009  Retinoic acid receptor agonist
0,051  0,030  Antiviral (Herpesvirus 3, Human)
0,135  0,114  Interleukin 6 antagonist
0,127  0,107  Antifungal (Cryptococcus)
0,055  0,035  Matrix metalloproteinase 1 inhibitor
0,053  0,033  Estrogen agonist
0,047  0,027  Estradiol 17 beta-dehydrogenase inhibitor
0,050  0,030  Glucose-6-phosphate isomerase inhibitor
0,062  0,043  Beta 2 adrenoreceptor agonist
0,155  0,136  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,040  0,022  Vanilloid 3 antagonist
0,022  0,005  Lysophosphatidic acid receptor 3 agonist
0,089  0,073  Creatine kinase inhibitor
0,034  0,018  Prostaglandin EP3 antagonist
0,030  0,015  Leukotriene D4 antagonist
0,081  0,066  Myeloperoxidase inhibitor
0,033  0,019  Prostaglandin D2 agonist
0,122  0,109  Hemostatic
0,071  0,058  Phosphodiesterase VI inhibitor
0,055  0,043  Acetyl-CoA transferase 2 inhibitor
0,108  0,096  Renal failure treatment
0,036  0,023  Retinoid X alpha receptor agonist
0,045  0,033  Neuraminidase (Influenza A) inhibitor
0,034  0,024  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,219  0,210  Transcription factor inhibitor
0,072  0,063  Metalloproteinase-2 inhibitor
0,051  0,043  Postmenopausal disorders treatment
0,128  0,120  Muscular dystrophy treatment
0,030  0,023  Squalene synthetase inhibitor
0,062  0,055  Phosphofructokinase-1 inhibitor
0,020  0,014  Retinoic acid alpha receptor antagonist
0,021  0,015  Lysophosphatidic acid 1 receptor antagonist
0,071  0,065  Narcotic antagonist
0,037  0,031  Retinoic acid alpha receptor agonist
0,136  0,130  Aldehyde oxidase substrate
0,049  0,044  Acetyl-CoA transferase inhibitor
0,019  0,014  Retinoic acid beta receptor agonist
0,016  0,011  Vitamin D receptor agonist
0,065  0,060  Cathepsin G inhibitor
0,037  0,033  Toll-Like receptor 2 agonist
0,122  0,118  Acute respiratory distress syndrome (ARDS) treatment
0,041  0,038  Dihydrofolate reductase inhibitor
0,107  0,104  Alkaline phosphatase inhibitor
0,034  0,031  Farnesoid X receptor agonist
0,095  0,092  Topoisomerase II inhibitor
0,060  0,057  Phenylalanine 4-hydroxylase inhibitor
0,015  0,013  Carbonic anhydrase VIII inhibitor
0,015  0,013  Carbonic anhydrase X inhibitor
0,030  0,028  Glutamate (mGluR3) agonist
0,020  0,018  Retinoid X beta receptor antagonist
0,011  0,010  Calcium-dependent phospholipase A2 inhibitor
0,014  0,013  Prostacyclin agonist
0,056  0,055  Prostaglandin F2 alpha antagonist
0,024  0,023  Thyroid hormone agonist
0,023  0,022  Prostaglandin EP4 antagonist
0,077  0,077  3C-Like protease (SARS coronavirus) inhibitor

